The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer’s disease
- 1 March 2012
- journal article
- Published by Springer Nature in Human Genetics
- Vol. 131 (7) , 1245-1249
Abstract
CD33 and MS4A6A genes play potential key roles in the pathogenesis of Alzheimer’s disease (AD). One recent genome-wide association study has revealed that the rs3865444 polymorphism in the CD33 gene and rs610932 polymorphism in the MS4A6A gene are associated with susceptibility to AD in Caucasians. To evaluate the relationship between the polymorphism of the CD33, MS4A6A gene and AD in the ethnic Chinese Han, we conducted a case–control study (n = 383, age > 54) to determine the prevalence of single-nucleotide polymorphism of two genes in patients with AD in Chinese population of Mainland, and clarified whether these polymorphisms are risk factors for AD. The prevalence of the allele (T) in the rs3865444 polymorphism of the CD33 gene and allele (C) in rs610932 polymorphism of the MS4A6A gene was significantly different in AD patients and control subjects (P < 0.001, respectively), and the results were not influenced by age, gender, or APOE status. Our data revealed the allele (T) of the rs3865444 polymorphism of the CD33 gene and the allele (C) of the rs610932 polymorphism of the MS4A6A gene may contribute to AD risk in the Chinese Han population.Keywords
This publication has 19 references indexed in Scilit:
- The three new pathways leading to Alzheimer's diseaseNeuropathology and Applied Neurobiology, 2011
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseNature Genetics, 2011
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseNature Genetics, 2011
- The Incidence and Prevalence of Alzheimer’s DiseaseNeurodegenerative Diseases, 2010
- Phylogenetic Analysis of the MS4A and TMEM176 Gene FamiliesPLOS ONE, 2010
- MS4A4B Is a GITR-Associated Membrane Adapter, Expressed by Regulatory T Cells, Which Modulates T Cell ActivationThe Journal of Immunology, 2009
- Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteriaThe Lancet Neurology, 2007
- Autoantibodies to Redox-modified Oligomeric Aβ Are Attenuated in the Plasma of Alzheimer's Disease PatientsJournal of Biological Chemistry, 2005
- Reduced levels of amyloid β-peptide antibody in Alzheimer diseaseNeurology, 2001
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992